Talaris Therapeutics Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Dilution of Shares: Shareholders have been substantially diluted in the past year, with total shares outstanding growing by 290.7%.

Top 25 shareholders own 80.72% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
18.9%	Blackstone Life Sciences	8,089,315	US$104.6m	0%	25.11%
11.9%	Suzanne Ildstad	5,079,802	US$65.7m	-8.68%	no data
7.53%	Longitude Capital Management Co., LLC	3,220,775	US$41.7m	0%	6.37%
6.86%	Qiming Weichuang Venture Capital Management (Shanghai) Company Limited	2,932,606	US$37.9m	0%	0.96%
5.46%	RA Capital Management, L.P.	2,333,175	US$30.2m	0%	0.14%
4.68%	BML Capital Management, LLC	2,000,000	US$25.9m	3.65%	5.19%
3.39%	Nantahala Capital Management, LLC	1,450,034	US$18.8m	0%	0.57%
2.43%	The Vanguard Group, Inc.	1,037,871	US$13.4m	-7.74%	no data
2.31%	Scott Requadt	988,169	US$12.8m	6.29%	no data
2.14%	Artal Group S.A.	914,262	US$11.8m	0%	0.1%
2.12%	Balyasny Asset Management L.P.	904,774	US$11.7m	0%	0.01%
1.56%	Great Point Partners, LLC	666,033	US$8.6m	0%	0.4%
1.38%	QVT Financial LP	589,314	US$7.6m	0%	0.1%
1.17%	Avoro Capital Advisors LLC	500,000	US$6.5m	0%	0.02%
1.15%	Acuitas Investments, LLC	491,141	US$6.4m	0%	0.6%
1.06%	JPMorgan Chase & Co, Brokerage and Securities Investments	452,354	US$5.9m	67,200%	no data
1.05%	HighTower Advisors, LLC	448,359	US$5.8m	0%	no data
1.03%	Renaissance Technologies LLC	440,800	US$5.7m	696%	no data
0.9%	Francois Nader	386,932	US$5.0m	-27.6%	no data
0.75%	Millennium Management LLC	322,084	US$4.2m	0%	no data
0.71%	Walleye Capital LLC	304,599	US$3.9m	0%	0.01%
0.68%	Scoggin Capital Management LLC	289,608	US$3.7m	0%	1.08%
0.56%	Nancy Krieger	238,667	US$3.1m	-4.62%	no data
0.53%	Two Sigma Investments, LP	226,415	US$2.9m	721%	no data
0.5%	Citadel Advisors LLC	213,754	US$2.8m	-79.6%	no data